Health
Scientists Identify Potential Drug Candidate Against Covid-19, Stops Virus from Replicating in Host Cells – News18
Ebselen, a chemical compound with anti-viral, anti-inflammatory, anti-oxidative, bactericidal and cell-protective properties, is used to treat bipolar disorder and loss of hearing.
Using state-of-the-art computer simulations, scientists have identified a preexisting drug, used to treat multiple diseases, including bipolar disorders and hearing loss, that could prevent the novel coronavirus from replicating in host cells, an advance that may lead to a therapeutic solution against COVID-19. The study, published in the journal Science Advances, assessed the molecule main protease, Mpro, of the novel coronavirus which is a key enzyme that plays a central role in its life cycle…
-
Noosa News24 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General23 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General23 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Business12 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?